Federico Verde, MD. He graduated in Medicine in 2011 from the Università degli Studi di Milano, where he obtained a specialization in Neurology in 2017 with a thesis on the measurement of serum neurofilament light chain with Simoa technology for the diagnosis of ALS, resulting from research conducted as a guest scientist in the Laboratory of Neurochemistry of the University of Ulm, Germany (July 2016–July 2017). He is a Fellow of the European Board of Neurology and a member of the Italian Society of Neurology (SIN), the Italian Association for Dementias (SINdem), and the international CSF Society. He holds a CSF Certificate (Liquor-Zertifikat) from the German Society of CSF Diagnostics and Clinical Neurochemistry (DGLN). His main clinical and research areas of interest are neurodegenerative diseases, particularly dementias and ALS, and neurochemical biomarkers. He is in charge of the outpatient dementia clinic at IRCCS Istituto Auxologico Italiano, Milan.